A Phase IIb Study of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPD
Clinical trial NCT06545500 · COMPLETED
Trial details
- NCT number
- NCT06545500
- Sponsor
- Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-16
- Primary completion
- 2025-01-02
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.